Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA
According to a story from prnewswire.com, the Chiesi Global Rare Diseases and the biopharmaceutical company ProTalix Biotherapeutics have recently announced that they have submitted a Biologics License Application (BLA) for…